Abstract
Purpose
Recent epidemiological evidence attempts to demonstrate the risk of pulmonary hypertension (PH) among patients with chronic kidney disease (CKD) without dialysis, but prevalence estimates of PH in CKD without dialysis vary widely in the existing studies. This meta-analysis was to summarize the point prevalence of PH in adults with CKD without dialysis.
Methods
PubMed, EMBASE, the Cochrane Collaboration, and the reference lists of relevant articles were searched to identify eligible studies. We used a random-effect meta-analysis model to estimate the prevalence of PH. Associations were tested in subgroups and meta-regression analyses. We also performed sensitivity analyses and assessments of publishing bias.
Results
Twenty-one observational studies (n = 8012 participants) were included in this meta-analysis. The result of analysis in random-effect model showed that the pooled prevalence was 32% (95% CI 23–42%), with significant heterogeneity between these studies (I2 = 98%, P < 0.01). Stratified analyses found that the study design, region, sample size, year of publication, and definition of PH based on PASP ≥ 35 mmHg may explain the variation between studies. Sensitivity analysis further demonstrated the results to be robust. There was no evidence of publication bias.
Conclusions
PH is highly prevalent in patients with CKD without dialysis. Owing to the high heterogeneity, future well-designed and large prospective studies are encouraged to confirm the findings and definitively clarify the potential biological mechanisms.
Similar content being viewed by others
Abbreviations
- CKD:
-
Chronic kidney disease
- PH:
-
Pulmonary hypertension
- PASP:
-
Pulmonary artery systolic pressure
- RHC:
-
Right heart catheterization
- TRV:
-
Tricuspid regurgitant velocity
References
Chadban SJ, Briganti EM, Kerr PG, Dunstan DW, Welborn TA, Zimmet PZ, Atkins RC (2003) Prevalence of kidney damage in Australian adults: the AusDiab kidney study. J Am Soc Nephrol 14(7 Suppl 2):S131–S138
Chen J, Wildman RP, Gu D, Kusek JW, Spruill M, Reynolds K, Liu D, Hamm LL, Whelton PK, He J (2005) Prevalence of decreased kidney function in Chinese adults aged 35 to 74 years. Kidney Int 68(6):2837–2845. https://doi.org/10.1111/j.1523-1755.2005.00757.x
Coresh J, Byrd-Holt D, Astor BC, Briggs JP, Eggers PW, Lacher DA, Hostetter TH (2005) Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 16(1):180–188. https://doi.org/10.1681/asn.2004070539
Hostetter TH (2004) Chronic kidney disease predicts cardiovascular disease. N Engl J Med 351(13):1344–1346. https://doi.org/10.1056/NEJMe048236
Galie N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M (2016) 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Revista espanola de cardiologia (English ed) 69(2):177. https://doi.org/10.1016/j.rec.2016.01.002
Archer S, Rich S (2000) Primary pulmonary hypertension: a vascular biology and translational research “Work in progress”. Circulation 102(22):2781–2791
Martin KB, Klinger JR, Rounds SI (2006) Pulmonary arterial hypertension: new insights and new hope. Respirology 11(1):6–17. https://doi.org/10.1111/j.1440-1843.2006.00778.x
Yigla M, Nakhoul F, Sabag A, Tov N, Gorevich B, Abassi Z, Reisner SA (2003) Pulmonary hypertension in patients with end-stage renal disease. Chest 123(5):1577–1582
Havlucu Y, Kursat S, Ekmekci C, Celik P, Serter S, Bayturan O, Dinc G (2007) Pulmonary hypertension in patients with chronic renal failure. Respiration 74(5):503–510
Abdelwhab S, Elshinnawy S (2008) Pulmonary hypertension in chronic renal failure patients. Am J Nephrol 28(6):990–997
Issa N, Krowka MJ, Griffin MD, Hickson LJ, Stegall MD, Cosio FG (2008) Pulmonary hypertension is associated with reduced patient survival after kidney transplantation. Transplantation 86(10):1384–1388
Yigla M, Banderski R, Azzam ZS, Reisner SA, Nakhoul F (2008) Arterio-venous access in end-stage renal disease patients and pulmonary hypertension. Ther Adv Respir Dis 2(2):49–53
Yigla M, Fruchter O, Aharonson D, Yanay N, Reisner SA, Lewin M, Nakhoul F (2009) Pulmonary hypertension is an independent predictor of mortality in hemodialysis patients. Kidney Int 75(9):969–975
Kiykim AA, Horoz M, Ozcan T, Yildiz I, Sari S, Genctoy G (2010) Pulmonary hypertension in hemodialysis patients without arteriovenous fistula: the effect of dialyzer composition. Ren Fail 32(10):1148–1152
Zlotnick DM, Axelrod DA, Chobanian MC, Friedman S, Brown J, Catherwood E, Costa SP (2010) Non-invasive detection of pulmonary hypertension prior to renal transplantation is a predictor of increased risk for early graft dysfunction. Nephrol Dial Transpl 25(9):3090–3096
Pabst S, Hammerstingl C, Hundt F, Gerhardt T, Grohe C, Nickenig G, Woitas R, Skowasch D (2012) Pulmonary hypertension in patients with chronic kidney disease on dialysis and without dialysis: Results of the pepper-study. PLoS ONE 7(4):e35310
Said K, Hassan M, Baligh E, Zayed B, Sorour K (2012) Ventricular function in patients with end-stage renal disease starting dialysis therapy: a tissue Doppler imaging study. Echocardiography 29(9):1054–1059
Emara MM, Habeb MA, Alnahal AA, Elshazly TA, Alatawi FO, Masoud AS (2013) Prevalence of pulmonary hypertension in patients with chronic kidney disease on and without dialysis. Egypt J Chest Dis Tuberc 62(4):761–768
Li Z, Liang X, Liu S, Ye Z, Chen Y, Wang W, Li R, Xu L, Feng Z, Shi W (2014) Pulmonary hypertension: Epidemiology in different CKD stages and its association with cardiovascular morbidity. PLoS ONE 9(12):e114392
Yang QM, Bao XR (2014) Pulmonary hypertension in patients with stage 1-3 chronic kidney disease. Genet Mol Res 13(3):5695–5703
Babua C, Kalyesubula R, Okello E, Kakande B, Sebatta E, Mungoma M, Mondo C (2015) Pattern and presentation of cardiac diseases among patients with chronic kidney disease attending a national referral hospital in Uganda: a cross sectional study. BMC Nephrol 16(1):126
Suresh H, Arun BS, Moger V, Swamy M (2017) Cardiorenal syndrome type 4: a study of cardiovascular diseases in chronic kidney disease. Indian Heart J 69(1):11–16
Selvaraj S, Shah SJ, Ommerborn MJ, Clark CR, Hall ME, Mentz RJ, Qazi S, Robbins JM, Skelton TN, Chen J, Gaziano JM, Djousse L (2017) Pulmonary hypertension is associated with a higher risk of heart failure hospitalization and mortality in patients with chronic kidney disease: the Jackson Heart Study. Circ Heart Fail. https://doi.org/10.1161/circheartfailure.116.003940
Reque J, Garcia-Prieto A, Linares T, Vega A, Abad S, Panizo N, Quiroga B, Boira EJC, Lopez-Gomez JM (2017) Pulmonary Hypertension is associated with mortality and cardiovascular events in chronic kidney disease patients. Am J Nephrol 45(2):107–114
O’Leary JM, Assad TR, Xu M, Birdwell KA, Farber-Eger E, Wells QS, Hemnes AR, Brittain EL (2017) Pulmonary hypertension in patients with chronic kidney disease: invasive hemodynamic etiology and outcomes. Pulm Circ 7(3):674–683
Navaneethan SD, Roy J, Tao K, Brecklin CS, Chen J, Deo R, Flack JM, Ojo AO, Plappert TJ, Raj DS, Saydain G, Sondheimer JH, Sood R, Steigerwalt SP, Townsend RR, Dweik RA, Rahman M (2016) Prevalence, predictors, and outcomes of pulmonary hypertension in CKD. J Am Soc Nephrol 27(3):877–886
Genctoy G, Arikan S, Gedik O (2015) Secondary hyperparathyroidism is associated with pulmonary hypertension in older patients with chronic kidney disease and proteinuria. Int Urol Nephrol 47(2):353–358. https://doi.org/10.1007/s11255-014-0889-5
Bolignano D, Lennartz S, Leonardis D, D’Arrigo G, Tripepi R, Emrich IE, Mallamaci F, Fliser D, Heine G, Zoccali C (2015) High estimated pulmonary artery systolic pressure predicts adverse cardiovascular outcomes in stage 2–4 chronic kidney disease. Kidney Int 88(1):130–136
Bolignano D, Rastelli S, Agarwal R, Fliser D, Massy Z, Ortiz A, Wiecek A, Martinez-Castelao A, Covic A, Goldsmith D, Suleymanlar G, Lindholm B, Parati G, Sicari R, Gargani L, Mallamaci F, London G, Zoccali C (2013) Pulmonary hypertension in CKD. Am J Kidney Dis 61(4):612–622. https://doi.org/10.1053/j.ajkd.2012.07.029
Sise ME, Courtwright AM, Channick RN (2013) Pulmonary hypertension in patients with chronic and end-stage kidney disease. Kidney Int 84(4):682–692. https://doi.org/10.1038/ki.2013.186
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62(10):1006–1012. https://doi.org/10.1016/j.jclinepi.2009.06.005
von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP (2014) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. Int J Surg (London, England) 12(12):1495–1499. https://doi.org/10.1016/j.ijsu.2014.07.013
Lv TT, Wang P, Guan SY, Li HM, Li XM, Wang B, Pan HF (2017) Prevalence of pulmonary hypertension in systemic lupus erythematosus: a meta-analysis. Ir J Med Sci. https://doi.org/10.1007/s11845-017-1727-4
Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088–1101
Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634
Yao Z, Wang C, Zhang Q, Ma S, Gui B, Duan C (2017) Prevalence of abdominal artery calcification in dialysis patients with end-stage renal disease: a systematic review and meta-analysis. Int Urol Nephrol 49(11):2061–2069. https://doi.org/10.1007/s11255-017-1685-9
Park M, Hsu CY, Li Y, Mishra RK, Keane M, Rosas SE, Dries D, Xie D, Chen J, He J, Anderson A, Go AS, Shlipak MG (2012) Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol 23(10):1725–1734. https://doi.org/10.1681/asn.2012020145
Giaid A (1998) Nitric oxide and endothelin-1 in pulmonary hypertension. Chest 114(3 Suppl):208s–212s
Jarava C, Marti V, Gurpegui ML, Merello JI, Rdez-Quesada B, Palma A (1993) Pulmonary calcification in chronic dialysis patients. Nephrol Dial Transpl 8(7):673–674
Simonneau G, Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, Gomez Sanchez MA, Krishna Kumar R, Landzberg M, Machado RF, Olschewski H, Robbins IM, Souza R (2013) Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 62(25 Suppl):D34–D41. https://doi.org/10.1016/j.jacc.2013.10.029
Author information
Authors and Affiliations
Contributions
JD and WS conceived and designed the study. WS, YR, and YL screened the abstract and full text, extracted the data, assessed the studies, and drafted the manuscript. WS, YL, WL, and HW performed the statistical analyses. WS, and JD revised the manuscript. All authors read the manuscript and approved the final version.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Shang, W., Li, Y., Ren, Y. et al. Prevalence of pulmonary hypertension in patients with chronic kidney disease without dialysis: a meta-analysis. Int Urol Nephrol 50, 1497–1504 (2018). https://doi.org/10.1007/s11255-018-1853-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-018-1853-6